Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.88 USD | +1.23% | -3.05% | -14.84% |
12:26pm | North American Morning Briefing : Tech Still in -2- | DJ |
Apr. 25 | JPMorgan Upgrades Doximity to Neutral Rating From Underweight, Price Target is $25 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.84% | 4.4B | |
+18.66% | 404B | |
+15.31% | 243B | |
+12.63% | 144B | |
+20.88% | 104B | |
+17.19% | 81.99B | |
+53.19% | 57.53B | |
+34.36% | 51.76B | |
+5.73% | 36.89B | |
+14.29% | 31.71B |
- Stock Market
- Equities
- DOCS Stock
- News Doximity, Inc.
- Doximity Sees FY 2023 Revenue at $424-$432 Million, vs CIQ Analyst Consensus of $432 Million